| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18517eb2d26130bef22aa5d201469de5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-534
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4816 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-534
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53 |
| filingDate |
2001-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fef91fbfffb435c16674a5e1cb7fa1d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d1bc34e1a19848857e5cc6eee807dcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41627c28df16ea6c6bacd1c2cfcb9658 |
| publicationDate |
2004-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6821532-B2 |
| titleOfInvention |
Methods and compositions for the treatment of benign prostatic hypertrophy |
| abstract |
This invention relates to a composition for use in treating benign prostatic hyperplasia including a saw palmetto extract provided in an oral controlled release formulation which allows release of active ingredients in the intestinal tract and which allows the maintenance of therapeutic levels of active agents in the bloodstream for prolonged periods of time. This invention also relates to a composition for improving the efficacy of a saw palmetto extract, a method of treating benign prostatic hypertrophy, and a method of improving the efficacy of a saw palmetto extract treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004247619-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006019454-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009232786-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8354126-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008036809-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8221803-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008036807-A2 |
| priorityDate |
2001-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |